- Clinical research jobs
- Study Start Up Associate II
Use our `search` to find similar offers.
Study Start Up Associate II
ICON Public Limited Corporation
This is an exciting opportunity to join ICON Study Start Up Associate II, Late Phase China Key responsibilities: Prepare, review contract negotiation with ex
This is an exciting opportunity to join ICON
Study Start Up Associate II, Late Phase
China
Key responsibilities: Prepare, review contract negotiation with external sites, working to project deadline to finalise study contracts You will be collaborating with multiple internal and external teams to coordinate the contract templates and budgets throughout the timeframe Completing contract amendment activities Other study start up activities as required including: ethics submissions, creating submissions packages, amendments to study documentation according to country guidelines in China
To succeed you will need: Bachelor's Degree preferably in life sciences will ensure your familiarity with regulatory guidelines and industry knowledge.
Minimum of 1 year of experience or understanding of clinical study start up requirements and activities.
Fluent in local language and English, you will possess excellent written and verbal communication and interpersonal skills enabling you to deal with queries in a timely manner.
You should be able to produce accurate work to tight deadlines within a pressurised environment
Benefits of Working in ICON :
Other than working with a great team of smart and energetic people, we also offer a very competitive benefits package. This varies from country to country so a dedicated recruiter will discuss this with you at interview stage.
We care about our people as they are the key to our success. We provide an open and friendly work environment where we empower people and provide them with opportunities to develop their long term career.
ICON is an equal opportunity employer, including disability/veteran, and committed to providing a workplace free of discrimination and harassment.
Job posted: 2020-07-15